+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tasigna - API Insight, 2022

  • PDF Icon

    Drug Pipelines

  • 30 Pages
  • January 2022
  • Region: Global
  • DelveInsight
  • ID: 4038816
"Tasigna - API 2022" report by the publisher provides product and API manufacturers details across US, Europe, China and India for Tasigna . It includes Tasigna overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Tasigna's patents information (US & EU). It also features the historical and forecasted sales of Tasigna 2024. The report also highlights Tasigna's market competition and emerging therapies which are in the same space as Tasigna

Methodology


Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the Report


A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
Patent information around Tasigna in United States (US) and Europe (EU) has been highlighted
API manufacturers for Tasigna in United States, Europe, China and India
The report contains historical and forecasted sales for Tasigna 2024
Enlists the market competition and emerging therapies in the space where Tasigna operates

Reasons to Buy


Establish a comprehensive understanding of the drug, Tasigna
Access to Tasigna's API manufacturers details to devise API procurement strategy for generic development
Plan generic developmental timelines around Tasigna's patents for the major markets- US and EU
Understand Tasigna's current and future growth through its historical and forecasted sales
Identify the current in-market competitors for Tasigna
Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
Identify the emerging players and their products operating in the same space as Tasigna.

Table of Contents

1. Report Introduction
2. Tasigna Overview
  • Product Description
  • Mechanism of Action
  • Dosage and Administration
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties
  • Safety and Efficacy of Tasigna
  • Clinical Trial Description
  • Adverse Reactions
  • Product Development Activities

3. Product Details
  • United States
  • Europe

4. Tasigna Global Sales Assessment
  • Historical Global Sales
  • Forecasted Global Sales

5. Patent Details
6. Global API Manufacturers Assessment
  • United States
  • Europe
  • China
  • India

7. Market Competitors8. Emerging Therapies
9. Appendix
  • Methodology
  • Consulting Services
  • About the Publisher
  • Contact Us
  • Disclaimer

List of Tables
Table 1: Tasigna Description
Table 2: Tasigna Product Details, United States
Table 3: Tasigna Product Details, Europe
Table 4: Tasigna , Historical Global Sales till 2021 (in million USD)
Table 5: Tasigna , Forecasted Global Sales from 2022-2024 (in million USD)
Table 6: Patent Details: Tasigna
Table 7: API Manufacturers Region wise
Table 8: API Manufacturers for United States
Table 9: API Manufacturers for Europe
Table 10: API Manufacturers for China
Table 11: API Manufacturers for India
Table 12: Tasigna Market Competitors
Table 13: Emerging Therapies
List of Figures
Figure 1: Tasigna
Figure 2: Tasigna , Historical Global Sales till 2017 (in million USD)
Figure 3: Tasigna , Forecasted Global Sales from 2020-2022 (in million USD)
Figure 4: Patent Details: Tasigna
Figure 5: API Manufacturers Region wise
Figure 6: Patent Details: Tasigna
Figure 7: API Manufacturers Region wise
Figure 8: API Manufacturers for United States
Figure 9: API Manufacturers for Europe
Figure 10: API Manufacturers for China
Figure 11: API Manufacturers for India
Figure 12: Tasigna Market Competitors
Figure 13: Emerging Therapies